-+ 0.00%
-+ 0.00%
-+ 0.00%

ORYZON Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026

Barchart·07/27/2026 13:23:00
Listen to the news

MADRID and CAMBRIDGE, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial results for the three months ended June 30, 2026, and provided a corporate update on recent developments.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.